NCT06644833View on ClinicalTrials.gov

Effective of Transcranial Magnetic Stimulation (TMS) vs Treatment as Usual for First-Episode Depression in Adults

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

December 30, 2028

Study Completion Date

June 1, 2029

Conditions

Major Depressive Disorder

Interventions

DEVICE

Transcranial magnetic stimulation

Transcranial Magnetic Stimulation (rTMS) sessions, targeting the dorsolateral prefrontal cortex, at a frequency of 10 Hz. Each session will last approximately 30 minutes, with 5 sessions per week for 4 to 6 weeks.

DRUG

Antidepressant

Selective serotonin reuptake inhibitors (SSRIs) or tricyclic antidepressants, SNRIs

All Listed Sponsors

lead

Sultan Qaboos University

OTHER